Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031)
- 1 January 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 24 (2) , 251-253
- https://doi.org/10.1007/bf00613827
Abstract
Summary The pharmacokinetics of chlorambucil has been investigated in a cross over study after oral administration of the free drug (10 mg) and its prednisolone ester (prednimustine, 100 mg). The bioavailability of chlorambucil was about five times lower when given as prednimustine as compared to administration of the free drug. The peak plasma concentration was about twice as high and it was obtained more rapidly when the free drug was given. No intact prednimustine could be detected in plasma.Keywords
This publication has 10 references indexed in Scilit:
- Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancerCancer, 1980
- Determination of chlorambucil in plasma by GLC with selected-ion monitoringJournal of Pharmaceutical Sciences, 1980
- Clinical Trial of Prednimustine, Leo‐1031 (NSC‐134087), in Patients with Non‐Hodgkin Lymphomata and Chronic Lymphocytic Leukaemia Previously Treated with Steroids and Alkylating AgentsActa Medica Scandinavica, 1980
- Effect of food on kinetics of 8‐methoxsalenClinical Pharmacology & Therapeutics, 1979
- PHASE-II STUDY OF LEO-1031 (PREDNIMUSTINE) IN ADVANCED OVARIAN-CARCINOMA1979
- Extramicrosomal drug metabolismEuropean Journal of Drug Metabolism and Pharmacokinetics, 1979
- Some Metabolic Aspects of a Nitrogen Mustard of PrednisoloneOncology, 1978
- MASS FRAGMENTOGRAPHIC DETERMINATION OF PREDNIMUSTINE AND CHLORAMBUCIL IN PLASMA1977
- Pivampicillin and ampicillin in bile, portal and peripheral bloodClinical Pharmacology & Therapeutics, 1976
- Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinomaPublished by Elsevier ,1975